Linagliptin API
| Name of Product | Linagliptin API |
|---|---|
| CAS No | 668270‑12‑0 |
| Therapeutic use:- | DPP‑4 inhibitor – glycemic control in type 2 diabetes |
| Grade | IH |
| Form:- | API Powder |
| Status | Commercial |
Product Overview
Linagliptin (CAS No. 668270-12-0) is an oral antidiabetic drug. It belongs to the Dipeptidyl Peptidase-4 (DPP-4) inhibitors class.
This product helps manage type 2 diabetes. It mainly does this by regulating blood sugar levels. However, remember that this is achieved without causing significant hypoglycemia.
Linagliptin is mostly cleared through the bile and the gut. This is different from other antidiabetic drugs. This is considered suitable for patients with renal impairment.
Therapeutic Applications
- Type 2 Diabetes Mellitus treatment involves controlling the glycemia.
- Known as combination therapy, it is prescribed with metformin, sulfonylureas, or insulin.
- Clinical studies support its cardiovascular safety profile.
Specification Parameters
The CAS number is 668270-12-0.
Molecular formula is C25H28N8O2.
Molecular weight: 472.55 g/mol
Sparingly soluble in water; soluble in DMSO and other solvents
Packaging & Storage
Linagliptin is typically packed in HDPE bottles, fiber drums, or aluminum foil packs, depending on customer requirements.
A dry, cool atmosphere and a moisture-free environment are preferred.
Why Choose Us
High-quality products are available from us, including Linagliptin. We follow strict guidelines from all countries. We ensure purity and consistency in our supplies.
Our team handles flexible packaging options, global shipping, and competitive pricing. We aim to provide comprehensive support to pharmaceutical companies, distributors, and research institutions.